Skip to main content

Peer Review reports

From: Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

Original Submission
8 May 2012 Submitted Original manuscript
22 May 2012 Author responded Author comments - Shannon Ferrante
Resubmission - Version 2
22 May 2012 Submitted Manuscript version 2
8 Oct 2012 Reviewed Reviewer Report - Gaby Sroczynski
30 Dec 2012 Reviewed Reviewer Report - Christian Lange
4 Jan 2013 Reviewed Reviewer Report - jihad slim
16 Feb 2013 Author responded Author comments - Shannon Ferrante
Resubmission - Version 3
16 Feb 2013 Submitted Manuscript version 3
18 Feb 2013 Author responded Author comments - Shannon Ferrante
Resubmission - Version 4
18 Feb 2013 Submitted Manuscript version 4
18 Feb 2013 Author responded Author comments - Shannon Ferrante
Resubmission - Version 5
18 Feb 2013 Submitted Manuscript version 5
22 Feb 2013 Reviewed Reviewer Report - Christian Lange
25 Feb 2013 Reviewed Reviewer Report - Gaby Sroczynski
5 Mar 2013 Author responded Author comments - Shannon Ferrante
Resubmission - Version 6
5 Mar 2013 Submitted Manuscript version 6
Publishing
22 Mar 2013 Editorially accepted
27 Apr 2013 Article published 10.1186/1471-2334-13-190

You can find further information about peer review here.

Back to article page